Cancer Research AACR Conference on Molecular Diagnostics - 2008  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 58, 2500-2503, June 15, 1998]
© 1998 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maxwell, G. L.
Right arrow Articles by Futreal, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maxwell, G. L.
Right arrow Articles by Futreal, P. A.

Mutation of the PTEN Tumor Suppressor Gene in Endometrial Hyperplasias1

G. Larry Maxwell, John I. Risinger, Curtis Gumbs, Heather Shaw, Rex C. Bentley, J. Carl Barrett, Andrew Berchuck2 and P. Andrew Futreal

Departments of Obstetrics and Gynecology/Division of Gynecologic Oncology [G. L. M., A. B., P. A. F.], Surgery [C. G., P. A. F.], Medicine [H. S.], and Pathology [R. C. B.], Duke University Medical Center, Durham, North Carolina 27710, and Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709 [J. I. R., J. C. B.]

Mutation and deletion of the PTEN tumor suppressor gene occurs in about 40% of endometrial carcinomas. The purpose of this study was to determine whether PTEN mutations also are present in endometrial hyperplasias, which are premalignant precursors of invasive endometrial adenocarcinomas. Genomic DNA from 51 endometrial hyperplasias was extracted from paraffin blocks, and PCR was used to amplify the nine exons of the PTEN gene. These products were screened using single-strand conformation analysis, and variant bands were sequenced. Somatic mutations in the PTEN gene were seen in 10 of 51 cases (20%), and two mutations were found in one case. An identical 4-bp deletion in exon 8 was seen in three cases, and 8 of 11 PTEN mutations predicted truncated protein products. There was no higher frequency of PTEN mutations in endometrial hyperplasias with atypia (6 of 32; 19%) relative to those without atypia (4 of 19; 21%). These data suggest that inactivation of the PTEN tumor suppressor gene is an early event in the development of some endometrial cancers.

1 Supported in part by the Duke University Specialized Programs of Research Excellence in Breast Cancer from the National Cancer Institute.

2 To whom requests for reprints should be addressed, at Division of Gynecologic Oncology, Duke University Medical Center, Box 3079, Durham, NC 27710. Phone: (919) 684-3765; Fax: (919) 684-8719.

Received 3/ 5/98. Accepted 4/28/98.




This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
G. W. Montgomery, D. R. Nyholt, Z. Z. Zhao, S. A. Treloar, J. N. Painter, S. A. Missmer, S. H. Kennedy, and K. T. Zondervan
The search for genes contributing to endometriosis risk
Hum. Reprod. Update, September 1, 2008; 14(5): 447 - 457.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
S. A. Treloar, Z. Z. Zhao, L. Le, K. T. Zondervan, N. G. Martin, S. Kennedy, D. R. Nyholt, and G. W. Montgomery
Variants in EMX2 and PTEN do not contribute to risk of endometriosis
Mol. Hum. Reprod., August 1, 2007; 13(8): 587 - 594.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
J. M Haughian, T. A Jackson, D. M Koterwas, and A. P Bradford
Endometrial cancer cell survival and apoptosis is regulated by protein kinase C {alpha} and {delta}
Endocr. Relat. Cancer, December 1, 2006; 13(4): 1251 - 1267.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. P. Hayes, H. Wang, R. Espinal-Witter, W. Douglas, G. J. Solomon, S. J. Baker, and L. H. Ellenson
PIK3CA and PTEN Mutations in Uterine Endometrioid Carcinoma and Complex Atypical Hyperplasia.
Clin. Cancer Res., October 15, 2006; 12(20): 5932 - 5935.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. L. Hecht and G. L. Mutter
Molecular and Pathologic Aspects of Endometrial Carcinogenesis
J. Clin. Oncol., October 10, 2006; 24(29): 4783 - 4791.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
I. Sansal and W. R. Sellers
The Biology and Clinical Relevance of the PTEN Tumor Suppressor Pathway
J. Clin. Oncol., July 15, 2004; 22(14): 2954 - 2963.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
F.-S. Liu, J.-T. Dong, J.-T. Chen, Y.-T. Hsieh, E. S.-C. Ho, M.-J. Hung, C.-H. Lu, and L.-C. Chiou
KAI1 Metastasis Suppressor Protein Is Down-Regulated during the Progression of Human Endometrial Cancer
Clin. Cancer Res., April 1, 2003; 9(4): 1393 - 1398.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. I. Risinger, G. L. Maxwell, G. V. R. Chandramouli, A. Jazaeri, O. Aprelikova, T. Patterson, A. Berchuck, and J. C. Barrett
Microarray Analysis Reveals Distinct Gene Expression Profiles among Different Histologic Types of Endometrial Cancer
Cancer Res., January 1, 2003; 63(1): 6 - 11.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
G L Mutter
Diagnosis of premalignant endometrial disease
J. Clin. Pathol., May 1, 2002; 55(5): 326 - 331.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
H. Wang, W. Douglas, M. Lia, W. Edelmann, R. Kucherlapati, K. Podsypanina, R. Parsons, and L. H. Ellenson
DNA Mismatch Repair Deficiency Accelerates Endometrial Tumorigenesis in Pten Heterozygous Mice
Am. J. Pathol., April 1, 2002; 160(4): 1481 - 1486.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
X.-P. Zhou, S. Kuismanen, M. Nystrom-Lahti, P. Peltomaki, and C. Eng
Distinct PTEN mutational spectra in hereditary non-polyposis colon cancer syndrome-related endometrial carcinomas compared to sporadic microsatellite unstable tumors
Hum. Mol. Genet., February 1, 2002; 11(4): 445 - 450.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. E. Hale, C. L. Hughes, and J. M. Cline
Endometrial Cancer: Hormonal Factors, the Perimenopausal ""Window of Risk,"" and Isoflavones
J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 3 - 15.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. Dicuonzo, S. Angeletti, J. Garcia-Foncillas, A. Brugarolas, Y. Okrouzhnov, D. Santini, G. Tonini, G. Lorino, M. De Cesaris, and A. Baldi
Colorectal Carcinomas and PTEN/MMAC1 Gene Mutations
Clin. Cancer Res., December 1, 2001; 7(12): 4049 - 4053.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Utsunomiya, T. Suzuki, C. Kaneko, J. Takeyama, J. Nakamura, K. Kimura, M. Yoshihama, N. Harada, K. Ito, R. Konno, et al.
The Analyses of 17{beta}-Hydroxysteroid Dehydrogenase Isozymes in Human Endometrial Hyperplasia and Carcinoma
J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3436 - 3443.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. Zhu, C.-H. Kwon, P. W. Schlosshauer, L. H. Ellenson, and S. J. Baker
PTEN Induces G1 Cell Cycle Arrest and Decreases Cyclin D3 Levels in Endometrial Carcinoma Cells
Cancer Res., June 1, 2001; 61(11): 4569 - 4575.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y. Kanamori, J. Kigawa, H. Itamochi, M. Shimada, M. Takahashi, S. Kamazawa, S. Sato, R. Akeshima, and N. Terakawa
Correlation between Loss of PTEN Expression and Akt Phosphorylation in Endometrial Carcinoma
Clin. Cancer Res., April 1, 2001; 7(4): 892 - 895.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
N. Sato, H. Tsunoda, M. Nishida, Y. Morishita, Y. Takimoto, T. Kubo, and M. Noguchi
Loss of Heterozygosity on 10q23.3 and Mutation of the Tumor Suppressor Gene PTEN in Benign Endometrial Cyst of the Ovary: Possible Sequence Progression from Benign Endometrial Cyst to Endometrioid Carcinoma and Clear Cell Carcinoma of the Ovary
Cancer Res., December 1, 2000; 60(24): 7052 - 7056.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
G. L. Maxwell, J. I. Risinger, K. A. Hayes, A. A. Alvarez, R. K. Dodge, J. C. Barrett, and A. Berchuck
Racial Disparity in the Frequency of PTEN Mutations, but not Microsatellite Instability, in Advanced Endometrial Cancers
Clin. Cancer Res., August 1, 2000; 6(8): 2999 - 3005.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
A. H. Holway, K. M. Rieger-Christ, W. R. Miner, J. W. Cain, J. M. Dugan, J. A. Pezza, M. L. Silverman, A. Shapter, R. McLellan, and I. C. Summerhayes
Somatic Mutation of PTEN in Vulvar Cancer
Clin. Cancer Res., August 1, 2000; 6(8): 3228 - 3235.
[Abstract] [Full Text]


Home page
JNCI J Natl Cancer InstHome page
I. U. Ali
Gatekeeper for Endometrium: the PTEN Tumor Suppressor Gene
J Natl Cancer Inst, June 7, 2000; 92(11): 861 - 863.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
G. L. Mutter, M.-C. Lin, J. T. Fitzgerald, J. B. Kum, J. P. A. Baak, J. A. Lees, L.-P. Weng, and C. Eng
Altered PTEN Expression as a Diagnostic Marker for the Earliest Endometrial Precancers
J Natl Cancer Inst, June 7, 2000; 92(11): 924 - 930.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. L. Mutter, M.-C. Lin, J. T. Fitzgerald, J. B. Kum, and C. Eng
Changes in Endometrial PTEN Expression throughout the Human Menstrual Cycle
J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2334 - 2338.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
M. Kiechle, M. Hinrichs, A. Jacobsen, J. Luttges, J. Pfisterer, F. Kommoss, and N. Arnold
Genetic Imbalances in Precursor Lesions of Endometrial Cancer Detected by Comparative Genomic Hybridization
Am. J. Pathol., June 1, 2000; 156(6): 1827 - 1833.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
X. Matias-Guiu, E. Bussaglia, L. Catasus, H. Lagarda, E. Gras, P. Machin, J. Prat, W. M. Lin, and C. Y. Muller
Correspondence re: W. M. Lin et al., Loss of Heterozygosity and Mutational Analysis of the PTEN/MMAC1 Gene in Synchronous Endometrial and Ovarian Carcinomas. Clin. Cancer Res., 4: 2577-2583, 1998.
Clin. Cancer Res., April 1, 2000; 6(4): 1598 - 1600.
[Full Text]


Home page
JNCI J Natl Cancer InstHome page
I. U. Ali, L. M. Schriml, and M. Dean
Mutational Spectra of PTEN/MMAC1 Gene: a Tumor Suppressor With Lipid Phosphatase Activity
J Natl Cancer Inst, November 17, 1999; 91(22): 1922 - 1932.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Esteller, L. Catasus, X. Matias-Guiu, G. L. Mutter, J. Prat, S. B. Baylin, and J. G. Herman
hMLH1 Promoter Hypermethylation Is an Early Event in Human Endometrial Tumorigenesis
Am. J. Pathol., November 1, 1999; 155(5): 1767 - 1772.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. Perren, L.-P. Weng, A. H. Boag, U. Ziebold, K. Thakore, P. L. M. Dahia, P. Komminoth, J. A. Lees, L. M. Mulligan, G. L. Mutter, et al.
Immunohistochemical Evidence of Loss of PTEN Expression in Primary Ductal Adenocarcinomas of the Breast
Am. J. Pathol., October 1, 1999; 155(4): 1253 - 1260.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. E. McMenamin, P. Soung, S. Perera, I. Kaplan, M. Loda, and W. R. Sellers
Loss of PTEN Expression in Paraffin-embedded Primary Prostate Cancer Correlates with High Gleason Score and Advanced Stage
Cancer Res., September 1, 1999; 59(17): 4291 - 4296.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M.-M. Georgescu, K. H. Kirsch, T. Akagi, T. Shishido, and H. Hanafusa
The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region
PNAS, August 31, 1999; 96(18): 10182 - 10187.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1998 by the American Association for Cancer Research.